Designing Longevity
Skip to main content

How We Vet Providers

Six dimensions, public weights, transparent disclosure, and a hard line against pay-to-rank. The methodology is the product.

The short version

Completed provider profiles use six weighted dimensions: licensure, accreditation, transparency, product quality, pricing, and customer service. The directory lists profiles alphabetically. Each provider score belongs to its dated profile review, separate from program-terms checks and exact Wegovy cash-pay plan ratings. We may earn a fee from links marked "We earn a fee". Our policy is to score providers using the published rubric and to disclose paid relationships beside the relevant links. Providers can be included without paying us. We do not accept payment for a higher ranking or per-prescription compensation.

The rubric

Six dimensions, weighted to a 0-5 overall score. Weights are public and stable. Each dimension is scored 0-5 with a one-line rationale on the provider's profile.

Licensure

20%

Active state pharmacy or medical license, no recent disciplinary actions in the last five years. Verified against the relevant state board lookup.

  • Active license in the states they claim to serve
  • No public disciplinary findings
  • No or 483 inspection observations
  • No active recalls

Accreditation

20%

Independent accreditation stack. We weight heavily for telehealth (it gates payment processing and ad eligibility) and heavily for compounding (it certifies sterile compounding practice).

  • Healthcare Merchant Certification (telehealth)
  • accreditation (Pharmacy Compounding Accreditation Board)
  • NABP Verified Pharmacy Program
  • USP <797> sterile compounding compliance

Transparency

20%

How much they let you see before you commit. Compounders that publish per-batch certificates of analysis () score highest. Telehealth that names every prescribing clinician and discloses formulation details scores higher than those that don't.

  • Per-batch available on request or published
  • Source pharmacy named ( vs )
  • Formulation and excipients disclosed
  • Pricing fully visible without intake

Product quality

15%

Independent test results when we can find them. We give credit for third-party lab testing, sterile facility certifications, and clean recall histories.

  • Third-party lab testing (, mass spec, )
  • Cold-chain shipping for stability-sensitive products
  • No quality-related recalls or contamination events

Pricing

15%

Value within the category, not absolute price. We compare against typical category pricing and give credit for clear refund policies and no-surprise billing.

  • Pricing within or below the category median
  • Clear refund policy published
  • No undisclosed fees or auto-renewal traps

Customer service

10%

Real-world support quality. We pull from , , Reddit, and direct user reports. Patterns matter more than individual complaints.

  • Responsive support (hours, channels, response time)
  • Adverse-event escalation path documented
  • Pattern of resolved (not just dismissed) complaints

Total weight: 100%. If the weighting changes, the change is in the git diff of data/providers.ts and this page is updated in the same commit.

What we verify

Current reviews rely on public records and published commentary. Direct questionnaires are planned, and independent test buys are not currently performed. A listing is an editorial assessment of available information, not certification of a provider or its products.

Tier 1: Public records

Public-record research includes state board lookups, the FDA warning-letter database, recall records, and accreditation directories where available. Individual claims show their sources and check dates; missing evidence should remain marked unverified.

Tier 2: Public commentary

BBB ratings, Trustpilot, Reddit threads (r/peptides, r/SemaglutideFreeSpeech, r/biohackers), state inspection reports where published. Noisy but useful at scale.

Tier 3: Direct questionnaire (planned)

A planned questionnaire would ask about testing reports, shipping conditions, refunds, adverse-event handling, and the source pharmacy. We do not claim that every listed provider has completed a questionnaire. A provider response would remain self-reported unless independently corroborated.

Tier 4: Independent test buys (not currently performed)

We do not currently buy products for independent laboratory testing. Our provider reviews use public records and published information; any laboratory report we discuss comes from an external source.

How we get paid

We may earn a fee from links marked "We earn a fee". Our policy is to score providers using the published rubric and to disclose paid relationships beside the relevant links. Providers can be included without paying us. We do not accept payment for a higher ranking or per-prescription compensation. A referral fee, when applicable, is paid by the provider.

We have a fixed set of compensation models we'll accept:

Per-click

Flat fee when a reader clicks through. Most common.

Per-qualified-consult

Flat fee when a reader books an intake consultation, regardless of whether they get a prescription.

Per-prescription

Never. Real anti-kickback exposure.

Pay-to-rank

Never. The methodology is the product.

Inclusion in the directory is independent of whether a provider pays us. Providers that meet the rubric but don't have an affiliate program get listed all the same; they just don't generate revenue for us. We disclose the relationship on every listing card with a small "We earn a fee" pill so you know which is which.

Hard lines we don't cross

Some of these are policy. Some are reflexes. All of them are non-negotiable for as long as we operate this directory.

We never accept per-prescription compensation. That's the model with real anti-kickback exposure under federal and state law, and we won't structure deals around it.

We never accept pay-to-rank. Affiliate relationship has zero effect on rubric scoring or directory ordering. The methodology is the product.

We never use FDA-approved-drug clinical trials (STEP, SURMOUNT, etc.) as substantiation for compounded versions. The National Advertising Division has been clear: those studies don't support claims for compounded products that may differ in API, formulation, or route.

We never make our own weight-loss or efficacy promises. Provider claims get framed as the provider's claim and don't carry our endorsement.

We never bury the affiliate disclosure. Disclosure appears adjacent to every affiliate link, on every page where it appears, every time.

Frequently asked

Do you accept money from the providers you list?+

We may earn a fee from links marked "We earn a fee". Our policy is to score providers using the published rubric and to disclose paid relationships beside the relevant links. Providers can be included without paying us. We do not accept payment for a higher ranking or per-prescription compensation.

Why isn't [provider X] in your directory?+

Two reasons typically: (1) they didn't meet the licensure or accreditation bar, or (2) we haven't gotten to them yet. We verify and write up providers in batches. Email us if you think a provider belongs and we'll prioritize them in the next review cycle.

How is the provider directory ordered?+

Profiles are listed alphabetically. Their six-dimension scores do not set directory order. A score reflects the evidence and review date on that provider's profile; some earlier scores are historical or withdrawn, as labeled. Separately dated program-terms checks and exact cash-pay plan ratings answer different questions and do not rank providers overall. Read the dated sources and scope before comparing.

What's the difference between a 503A and 503B compounding pharmacy?+

pharmacies compound for individual patients with a specific prescription. pharmacies are FDA-registered outsourcing facilities that can compound at larger scale and ship to clinics without patient-specific prescriptions. For , and most major payment processors require sourcing from accredited compounders, and 503B status is the strongest signal. We note compounding-pharmacy type and accreditation when the provider discloses it.

How do you weigh BBB ratings vs Trustpilot ratings?+

Differently, because they measure different things. ratings reflect how a business handles formal complaints over time; A+ accredited since 2018 is meaningfully stronger than F not accredited because it shows complaint-resolution behavior, not just complaint volume. averages reflect what individual customers post, where the most upset users dominate; we read the distribution (what percentage are 1-star) more than the average, and we weight Trustpilot's own suspected-fraudulent-review notice more heavily than the headline number when one is present. is a useful third signal, especially on volume. The honest framing: read all three, weight the disagreements as informative rather than noise.

What does an FDA warning letter mean for a provider in your directory?+

An describes violations identified by the agency and requests corrective action. Its implications depend on the findings, later responses, and any subsequent enforcement. Our profiles distinguish a letter naming a provider from an alert about a broader product category. Check the date and linked FDA record; an absence of a letter in our review does not establish that a provider is compliant.

Why do you list providers with active manufacturer lawsuits?+

Because civil litigation is not the same as regulatory enforcement, and most of the major manufacturer lawsuits in this category (Novo Nordisk and Eli Lilly against compounders) are about marketing claims rather than product safety. We surface the lawsuit prominently in the regulatory-history section, link the docket where possible, and note where the case stands (filed, partial dismissal, settlement). A live lawsuit lowers the licensure score but does not automatically disqualify a provider; what matters is the substance of the claim and whether the platform has continued the behavior post-filing.

What's LegitScript Healthcare Merchant Certification, and why does it matter?+

is a third-party verification organization that audits telehealth platforms and pharmacies for compliance with federal/state law and consumer-safety standards. Its certification is required by Google, Meta, TikTok, Microsoft, and most major credit-card processors before a healthcare merchant can advertise or accept payment. The catch is that LegitScript does not publish a public per-merchant directory we can verify against, so for some providers we mark certification as inferred (from the fact that they are advertising on Google or Meta, which gates on it) rather than verified. We err on the side of marking unverified when we cannot point to a public source.

How do you handle vertically-integrated providers vs partner-pharmacy models?+

Vertical integration (the platform owns the pharmacy that fills its prescriptions) is a transparency advantage we score in the Transparency dimension because it makes per-fill sourcing a non-question. Partner-pharmacy models (the platform routes prescriptions to one or more or partners) are not inherently worse, but they require additional disclosure: we look for whether the partner is named per fill, whether per-batch are published, and whether the partner is itself accredited. Most cohort providers run partner models without per-fill disclosure, which lowers the Transparency score relative to vertically-integrated competitors.

What disqualifies a provider from the directory entirely?+

Hard disqualifiers: no active state license in the states they claim to serve, an open FDA recall on a product line we'd be referring readers to, a pattern of unaddressed complaints that suggests the company has stopped responding, or a revenue model that requires per-prescription compensation (which has Anti-Kickback Statute exposure). Soft disqualifiers that lower the score but don't automatically remove the listing: recent , active manufacturer lawsuits, BBB ratings of D or F, suspected-fraudulent-review notices, and any opaque vendor management with downstream quality concerns.

How often do you re-verify?+

We aim to recheck provider public records quarterly, but this is a review target rather than a guarantee. Use the last verified date on each profile and the dates on individual checks. Older information may be out of date; confirm current pricing and availability with the provider before committing.

What if a score changes between when I read the page and now?+

Every meaningful score change is logged in the provider's update history with a date and a one-sentence rationale, so you can see the rationale even after the fact. Material changes (a major flag added, a settlement closing a previously-open lawsuit, a new accreditation verified) trigger a re-publish with the date stamped at the top. We don't silently re-score; the diff is in the git history of data/providers.ts and in the update-history section of the profile.

I had a bad experience with a provider you listed. What do I do?+

Email us with the details. If it's a one-off we note it and watch for patterns. If it's representative of broader issues, the listing comes down or gets re-scored. We'd rather de-list a provider than defend one we shouldn't have listed.

How is this page different from the head-to-head comparisons?+

This page explains the provider-profile rubric, verification process, and payment policies. Head-to-head pages at /providers/compare address narrower questions using their own dated evidence. A supported use-case verdict applies to that decision; it does not turn a historical provider score or an exact-plan rating into an overall provider ranking.

See the methodology applied

The directory lists dated provider profiles alphabetically. Head-to-head comparisons address specific decisions with their own source dates and limits.

Apply these checks to the service you are comparing

Trust pages worth knowing about: public corrections log · what we don't cover · press kit.

Have a provider you think we should evaluate? Get in touch.

Last reviewed October 9, 2026. Originally published April 15, 2026.